LY2603618 combined with Pemetrexed and Cisplatin (#388)
Laufzeit: 01.01.2010 - 31.12.2015
imported
Kurzfassung
A phase 1/ randomized phase 2 study to evaluate
LY2603618 in combination with Pemetrexed and Cisplatin
in patients with stage IV Non-small Cell Lung Cancer
